Alpha Teknova (TKNO) Competitors

Alpha Teknova (NASDAQ:TKNO) and Syndax Pharmaceuticals (NASDAQ:SNDX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, dividends, profitability, community ranking, analyst recommendations, institutional ownership and risk.

Is TKNO or SNDX more profitable?

Syndax Pharmaceuticals has a net margin of 0.00% compared to Alpha Teknova's net margin of -87.17%. Alpha Teknova's return on equity of -35.30% beat Syndax Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alpha Teknova	-87.17%	-35.30%	-24.52%
Syndax Pharmaceuticals	N/A	-64.34%	-57.72%

Does the MarketBeat Community believe in TKNO or SNDX?

Syndax Pharmaceuticals received 382 more outperform votes than Alpha Teknova when rated by MarketBeat users. Likewise, 65.38% of users gave Syndax Pharmaceuticals an outperform vote while only 39.13% of users gave Alpha Teknova an outperform vote.

Company	Underperform	Outperform
Alpha Teknova	Outperform Votes 9 39.13%	Underperform Votes 14 60.87%
Syndax Pharmaceuticals	Outperform Votes 391 65.38%	Underperform Votes 207 34.62%

Do analysts prefer TKNO or SNDX?

Alpha Teknova currently has a consensus price target of $8.50, indicating a potential upside of 45.80%. Syndax Pharmaceuticals has a consensus price target of $36.20, indicating a potential upside of 219.51%. Given Syndax Pharmaceuticals' higher probable upside, analysts clearly believe Syndax Pharmaceuticals is more favorable than Alpha Teknova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Teknova	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
Syndax Pharmaceuticals	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90

Which has higher valuation and earnings, TKNO or SNDX?

Alpha Teknova has higher revenue and earnings than Syndax Pharmaceuticals. Alpha Teknova is trading at a lower price-to-earnings ratio than Syndax Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Teknova	$37.75M	8.25	-$36.78M	-$0.59	-9.88
Syndax Pharmaceuticals	$23.68M	41.17	-$209.36M	-$3.73	-3.04

Does the media prefer TKNO or SNDX?

In the previous week, Syndax Pharmaceuticals had 6 more articles in the media than Alpha Teknova. MarketBeat recorded 7 mentions for Syndax Pharmaceuticals and 1 mentions for Alpha Teknova. Alpha Teknova's average media sentiment score of 1.87 beat Syndax Pharmaceuticals' score of 0.65 indicating that Alpha Teknova is being referred to more favorably in the media.

Company	Overall Sentiment
Alpha Teknova	Very Positive
Syndax Pharmaceuticals	Positive

Which has more volatility & risk, TKNO or SNDX?

Alpha Teknova has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500. Comparatively, Syndax Pharmaceuticals has a beta of 1.28, suggesting that its share price is 28% more volatile than the S&P 500.

Do insiders and institutionals believe in TKNO or SNDX?

13.8% of Alpha Teknova shares are held by institutional investors. 15.2% of Alpha Teknova shares are held by insiders. Comparatively, 4.1% of Syndax Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Alpha Teknova and Syndax Pharmaceuticals tied by winning 9 of the 18 factors compared between the two stocks.